Persistent atrial fibrillation (AFib) is a chronic condition characterized by an irregular heartbeat, sometimes leading to blood clots, stroke, or heart failure. It’s almost always progressive and often difficult to manage with medication alone.
But with robotic hybrid ablation, a two-step procedure that creates small scars in the heart tissue to block abnormal electrical signals, we can help provide you with lasting relief. This new treatment option combines robotic minimally invasive surgery with traditional catheter-based methods, creating a reinforced approach that reduces recovery time and lowers the risk of complications.
Living with persistent AFib can be scary, which is why we’re committed to advancing treatment using the latest technologies for improving your quality of life.
Robotic hybrid ablation offers a significant chance at lasting relief from persistent AFib and can be especially beneficial if you’ve had the condition for more than a year. It is also a potentially effective option if you’ve previously had catheter ablations but continue to experience AFib.
We offer a two-stage procedure that focuses on controlling your heart’s erratic signals and restoring normal electrical pathways. The combination of each stage allows us to more effectively block the erratic signals both on the outside and the inside of the heart.
The first stage involves the Da Vinci Robotic System, which helps us correct problems on the outside of your heart through minimally invasive techniques. The robot gives your surgeon better visibility and control, maximizing their ability to perform an effective surgery.
The second stage focuses on the inside of your heart and is non-surgical, performed by an expert in the heart’s electrical activity (an electrophysiologist) rather than a surgeon. This step helps ensure success, particularly if you are suffering from a complex case of AFib.
“By combining these two complementary techniques, the robotic hybrid procedure enhances the success rate of AFib treatment, offering patients a better chance at long-term rhythm control and reducing their risk of stroke, heart failure, and other AFib-related complications.”
You can expect a hospital stay of about one to two days. There are typically no activity restrictions post-surgery, and most people are able to resume daily activities within about a week.
Please note it’s normal to experience surgical pain for the first 24-72 hours after your surgery. If you notice more adverse symptoms, contact your care team or seek emergency care.
Call our cardiothoracic surgery outpatient clinic at 909-558-4208 for more information or ask your primary care provider for a referral.
With your help, we can make ambitious innovations in clinical care and education for our community.
